newsfilter
← Latest News
PR Newswire·

Liminal BioSciences Regains Compliance with NASDAQ Minimum Bid Price Requirement

LAVAL, QC, Feb. 15, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), announced that it has received written notice from The Nasdaq Stock Market LLC